PIN44 Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis: A Canadian Cost-Utility Analysis

Autor: Beauchemin, C., Guinan, K., Mathurin, K., Dufresne, S.F., Rotstein, C., Claveau, D., Landry, L., Lachaine, J.
Zdroj: In Value in Health December 2020 23 Supplement 2:S551-S552
Databáze: ScienceDirect